华润医药2024中期报告
Corporate Profile China Resources Pharmaceutical Group Limited (stock code: 3320) is aleading integrated pharmaceutical company in China. Our businessencompasses manufacturing, distribution and retail of pharmaceuticaland healthcare products. Since the establishment in 2007, the Group hasdeveloped into one of the top 5 pharmaceutical manufacturers and oneof the top 3 pharmaceutical distributors (by revenue) in China. 3320 In October 2016, the Company successfully completed its global offeringin Hong Kong. Our manufacturing business encompasses the researchand development, manufacturing and sale of pharmaceutical andhealthcare products. We manufacture 792 products, 430 of which wereincluded in the China’s national reimbursement drug list. The productscomprise chemical drugs, Chinese medicines and biological drugs as wellas nutritional and healthcare products, covering a wide range oftherapeutic areas including cardiovascular, alimentary tract andmetabolism, large-volume intravenous infusion, pediatrics, respiratorysystem, dermatology, etc. Moreover, we own a range of famous brands,such as “999”, “Dong-E-E-Jiao”, “Double Crane”, “Zizhu”,“Jiangzhong”, “Boya” and “Kun Zhong Yao”, covering therapeutic areasincluding cold, gastroenterology, dermatology, pediatrics, orthopedics,plasma products, among others. In future, we will actively expand intohealth management and products for chronic disease management tomeet the full-cycle and multi-dimensional healthcare needs of Chinesehouseholds from prevention, healthcare, therapy to recovery. 792430999 70 We regard R&D and product innovation as important drivers for our long-term growth and consistently increase the investment in R&D activities.We operate one national key laboratory, five national engineeringtechnology research centers, one national industrial innovation center,three national enterprise technology centers, over 70 provincial R&Dplatforms, and a post-doctoral research workstation. Leveraging our comprehensive product supply and wide distributionnetworks, we directly distribute products to hospitals and other medicalinstitutions across the country. We operate a national distributionnetwork comprising over 220 logistics centers strategically across 28provinces, municipalities and autonomous regions in China, with morethan 210,000 clients, including over 10,000 second- and third-classhospitals and approximately 90,000 primary medical institution clients. Inaddition, we operate one of the largest retail pharmacy networks inChina, comprising 760 retail pharmacies under national or regionalpremium brands — “CR Care ()” and “Teck Soon Hong ()”,including 275 DTP specialty pharmacies (which cover 162 “dual channel()” pharmacies). 2202821760DTP275162 Corporate Information BOARD OF DIRECTORS Chairman and Non-executive DirectorMr. Han Yuewei (resigned on 29 August 2024) Chairman and Executive DirectorMr. Bai Xiaosong (appointed as the Chairman and resigned asthe Chief Executive Officer on 29 August 2024) Executive Director and Vice PresidentMr. Tao Ran Executive Director and Chief Financial OfficerMdm. Deng Rong Non-executive Directors Mdm. Guo WeiMr. Sun YongqiangMr. Guo Chuan (appointed on 7 June 2024)Mdm. Jiao RuifangMr. Hou Bo (resigned on 7 June 2024) Independent Non-executive Directors Mdm. Shing Mo Han YvonneMr. Kwok Kin FunMr. Fu TingmeiMr. Zhang Kejian AUDIT COMMITTEE Mdm. Shing Mo Han Yvonne(Chairman)Mdm. Guo WeiMdm. Jiao RuifangMr. Kwok Kin FunMr. Fu TingmeiMr. Zhang Kejian Corporate Information NOMINATION COMMITTEE Mr. Han Yuewei(Chairman)(resigned on 29 August 2024)Mr. Bai Xiaosong(Chairman)(appointed on 29 August 2024)Mdm. Shing Mo Han YvonneMr. Kwok Kin FunMr. Fu TingmeiMr. Zhang Kejian REMUNERATION AND APPRAISAL COMMITTEE Mr. Kwok Kin Fun(Chairman)Mr. Sun YongqiangMdm. Shing Mo Han YvonneMr. Fu TingmeiMr. Zhang Kejian CORPORATE GOVERNANCE COMMITTEE Mr. Fu Tingmei(Chairman)Mr. Bai Xiaosong (resigned on 29 August 2024)Mdm. Deng Rong (appointed on 29 August 2024)Mdm. Shing Mo Han YvonneMr. Kwok Kin FunMr. Zhang Kejian EXECUTIVE COMMITTEE Mr. Bai Xiaosong(Chairman)Mr. Tao RanMdm. Deng Rong AUTHORIZED REPRESENTATIVES Mr. Bai XiaosongMs. Cheng Kwai Yuk (appointed on 24 April 2024)Mr. So Yiu Fung (resigned on 24 April 2024) COMPANY SECRETARY Ms. Cheng Kwai Yuk (appointed on 24 April 2024)Mr. So Yiu Fung (resigned on 24 April 2024) LEGAL ADVISORS Clifford ChanceJia Yuan Law Offices AUDITOR KPMGPublic Interest Entity Auditor registered in accordance withthe Accounting and Financial Reporting Council Ordinance8th Floor, Prince’s Building10 Chater Road, Central, Hong Kong 108 REGISTERED OFFICE 41/F, China Resources Building26 Harbour RoadWanchaiHong Kong 2641 SHARE REGISTRAR Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong 1617 Corporate Information PRINCIPAL BANKERS Agricultural Bank of China Ltd., Hong Kong BranchAgricultural Bank of China Beijing Xicheng Sub-BranchBank of Ch
